JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, cilt.28, sa.10, ss.1170-1175, 2015 (SCI-Expanded)
Background: Pentraxin 3 (PTX3) is an acute phase reactant which has been used to detect intra-amniotic infections (IAI) in pregnancy, but the prognostic value of PTX3 concentrations on neonates has not been studied. We aimed to investigate the relationship between maternal PTX3-neonatal PTX3 concentrations and early neonatal outcome.